Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,496 shares at $103.35 ($671K) on 2020-02-07, disclosed to the SEC on 2020-02-11.
Seasonal sale ($671k) by Chief Executive Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.35 | 3,248 | $336K | 50.0% |
| 2 | $103.35 | 3,248 | $336K | 50.0% |
| Total | $103.35 avg | 6,496 | $671K | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |